Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial
Authors:
Open Access
- 17 September 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 22 (12) , 1609-1617
Abstract
Background. The complexity of treatment regimens, costs and pill burden decrease the medication adherence and contribute to shortfall in cardiovascularKeywords
This publication has 22 references indexed in Scilit:
- Randomized Polypill Crossover Trial in People Aged 50 and OverPLOS ONE, 2012
- A policy review of the community health worker programme in IranJournal of Public Health Policy, 2011
- A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health OrganizationTrials, 2011
- A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factorsInternational Journal Of Clinical Practice, 2010
- Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern IranInternational Journal of Epidemiology, 2009
- Process evaluation of a community-based program for prevention and control of non-communicable disease in a developing country: The Isfahan Healthy Heart Program, IranBMC Public Health, 2009
- Balance algorithm for cluster randomized trialsBMC Medical Research Methodology, 2008
- The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countriesBulletin of the World Health Organization, 2007
- The Preventive Polypill — Much Promise, Insufficient EvidenceNew England Journal of Medicine, 2007
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002